Amyotrophic lateral sclerosis: promising therapeutic outcome-not far away?
نویسندگان
چکیده
منابع مشابه
Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
1Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, USA 2Department of Neurosciences, University of Toledo Medical Center, Toledo, OH 43614, USA 3Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA 4Department of Neurology, Hannover Medical School, Hannover, 30625, Germany 5Center for Translational Neuroscience, Department of Neurobio...
متن کاملGEMALS: A promising therapy for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that currently has no cure. At present, the only approved treatment for ALS is Riluzole, a glutamate release blocker that improves life expectancy by 3-6 months. ALS-Endotherapia (GEMALS) is a novel therapeutic approach to treat ALS and the aim of the present study was to investigate the potential beneficial effects of this nove...
متن کاملAmyotrophic Lateral Sclerosis
Touch MEdical MEdia 53 Fasciculation, which is observed in various peripheral motor neuron disorders, is most frequently found in nonprogressive benign fasciculation syndrome (BFS). Patients with BFS never exhibit muscle atrophy or pathologic weakness and not all such patients visit hospitals; therefore, the prevalence and characteristics of BFS still need to be established. However, among the ...
متن کامل[Amyotrophic lateral sclerosis].
Amyotrophic lateral sclerosis (ALS) is a progressive, degenerative disease of the motor system characterized by signs and symptoms of upper and lower motor dysfunction. This results in the presence of focal amyotrophies and pareses affecting voluntary muscles. Patients die after a few years, in most cases by respiratory failure. ALS is the most frequent motor neuron disease; however, its etiolo...
متن کاملAmyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting 20,000 to 30,000 people in the United States. The mainstay of care of patients affected by this disease is supportive and given the multifaceted nature of their needs is provided most efficiently through multidisciplinary clinics that have shown to prolong survival and improve quality of life. The authors ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neural Regeneration Research
سال: 2016
ISSN: 1673-5374
DOI: 10.4103/1673-5374.182715